Exercise program for older adults with liver cancer before surgery
Feasibility of Exercise Prehabilitation Among Older Patients With Hepatobiliary Cancer Planning for Surgery
This study tests if an exercise program can help older adults with liver cancer get stronger and recover better before their surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute Academic / other |
| Locations | 1 site (Tampa, Florida) |
| Trial ID | NCT05921552 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an exercise program specifically designed for senior adults diagnosed with hepatobiliary cancer who are preparing for surgery. Participants will engage in both resistance and aerobic training to assess improvements in their physical condition prior to undergoing liver resection. The study aims to determine if prehabilitation can enhance surgical outcomes and recovery for these patients. The research is being conducted at the H. Lee Moffitt Cancer Center and Research Institute.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 65 and older with resectable hepatobiliary cancers who are scheduled for surgery.
Not a fit: Patients who are younger than 65 or have unresectable liver cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could improve surgical outcomes and recovery times for older adults with liver cancer.
How similar studies have performed: Other studies have shown positive outcomes with prehabilitation programs in surgical patients, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥65 years * Resectable Hepatocellular carcinoma, Cholangiocarcinoma, or Liver metastasis with Liver resection planned ≥4 weeks * ECOG 0-2 * Able to sign consent Exclusion Criteria: * Does not meet inclusion criteria
Where this trial is running
Tampa, Florida
- Moffitt Cancer Center — Tampa, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Mohammed Al-Jumayli, MD — Moffitt Cancer Center
- Study coordinator: Mohammed Al-Jumayli, MD
- Email: Mohammed.AlJumayli@moffitt.org
- Phone: 813-745-8658
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.